Treatment with HMG-CoA Reductase Inhibitors (STATINS) is Associated with Preservation of Hepatic Function in Advanced Chronic Liver Disease (CLD): Results from the SHUNT-V Study.

Treatment with HMG-CoA Reductase Inhibitors (STATINS) is Associated with Preservation of Hepatic Function in Advanced Chronic Liver Disease (CLD): Results from the SHUNT-V Study.

August 2021

Source: Hepatology 2021; Presented at AASLD 2021.

Publication: